A Study of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C Mutation

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

442

Participants

Timeline

Start Date

August 3, 2022

Primary Completion Date

February 28, 2027

Study Completion Date

February 28, 2027

Conditions
KRAS P.G12C
Interventions
DRUG

D3S-001

Oral

DRUG

Pembrolizumab

Intravenous

DRUG

Cisplatin

Intravenous

DRUG

Carboplatin

Intravenous

DRUG

Pemetrexed

Intravenous

DRUG

Cetuximab

Intravenous

Trial Locations (49)

2109

RECRUITING

D3 Bio Investigative Site 0102, Sydney

3000

RECRUITING

D3 Bio Investigative Site 0105, Melbourne

3144

RECRUITING

D3 Bio Investigative Site 0101, Malvern

5042

RECRUITING

D3 Bio Investigative Site 0104, Bedford Park

6009

RECRUITING

D3 Bio Investigative Site 0103, Nedlands

10060

RECRUITING

D3 Bio Investigative Site 0905, Candiolo

20141

RECRUITING

D3 Bio Investigative Site 0902, Milan

20249

RECRUITING

D3 Bio Investigative Site 1002, Hamburg

28046

RECRUITING

D3 Bio Investigative Site 0704, Madrid

28050

RECRUITING

D3 Bio Investigative Site 0705, Madrid

28644

RECRUITING

D3 Bio Investigative Site 0204, Cheongju-si

33000

RECRUITING

D3 Bio Investigative Site 0804, Bordeaux

35033

RECRUITING

D3 Bio Investigative Site 0801, Rennes

37203

RECRUITING

D3 Bio Investigative Site 0405, Nashville

43000

RECRUITING

D3 Bio Investigative Site 0309, Wuhan

46010

RECRUITING

D3 Bio Investigative Site 0703, Valencia

46026

RECRUITING

D3 Bio Investigative Site 0702, Valencia

69373

RECRUITING

D3 Bio Investigative Site 0803, Lyon

77030

RECRUITING

D3 Bio Investigative Site 0403, Houston

80131

RECRUITING

D3 Bio Investigative Site 0904, Napoli

92868

RECRUITING

D3 Bio Investigative Site 0402, Orange

94805

RECRUITING

D3 Bio Investigative Site 0802, Villejuif

100036

RECRUITING

D3 Bio Investigative Site 0303, Beijing

110042

RECRUITING

D3 Bio Investigative Site 0302, Shenyang

150081

RECRUITING

D3 Bio Investigative Site 0307, Harbin

200030

RECRUITING

D3 Bio Investigative Site 0301, Shanghai

201801

RECRUITING

D3 Bio Investigative Site 0308, Shanghai

230000

RECRUITING

D3 Bio Investigative Site 0314, Hefei

250117

RECRUITING

D3 Bio Investigative Site 0310, Jinan

310003

RECRUITING

D3 Bio Investigative Site 0311, Hangzhou

310022

RECRUITING

D3 Bio Investigative Site 0305, Hangzhou

330008

RECRUITING

D3 Bio Investigative Site 0304, Nanchang

410013

RECRUITING

D3 Bio Investigative Site 0315, Changsha

430079

RECRUITING

D3 Bio Investigative Site 0312, Wuhan

450003

RECRUITING

D3 Bio Investigative Site 0313, Zhengzhou

510120

RECRUITING

D3 Bio Investigative Site 0306, Guangzhou

610041

RECRUITING

D3 Bio Investigative Site 0316, Chengdu

999077

RECRUITING

D3 Bio Investigative Site 0501, Shatin

80218-1238

RECRUITING

D3 Bio Investigative Site 0404, Denver

34232-6410

RECRUITING

D3 Bio Investigative Site 0406, Sarasota

48202-2608

RECRUITING

D3 Bio Investigative Site 0401, Detroit

00144

RECRUITING

D3 Bio Investigative Site 0901, Rome

277-8577

RECRUITING

D3 Bio Investigative Site 0601, Kashiwa

104-0045

RECRUITING

D3 Bio Investigative Site 0602, Tokyo

06591

RECRUITING

D3 Bio Investigative Site 0202, Seoul

120-752

RECRUITING

D3 Bio Investigative Site 0203, Seoul

138-736

WITHDRAWN

D3 Bio Investigative Site 0201, Seoul

08023

RECRUITING

D3 Bio Investigative Site 0706, Barcelona

08035

RECRUITING

D3 Bio Investigative Site 0701, Barcelona

All Listed Sponsors
lead

D3 Bio (Wuxi) Co., Ltd

INDUSTRY